Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns
📍 Where it landed
{"error": "Conflicting output format instructions. System prompt requested ONLY a valid, parseable JSON, while user prompt requested plain text only.
System prompt takes precedence, but since user requested plain text without JSON, the request is contradictory. Providing a JSON-formatted response to satisfy the strict JSON requirement."}
Epilogue added 22d ago, after coverage quieted.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
What happened
- Velocity & Diffusion: Coverage escalated across 6 distinct news outlets with 6 published articles, achieving a live velocity of 4.
- Predictive Outlook: Newsylist algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns" developed substantial multi-source reporting across the Business sector, tracked across 6 distinct newsrooms by Newsylist.
Key reporting was led by Lupus Foundation of America, proactiveinvestors.co.uk, EMJ and Seeking Alpha. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.
Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 22d ago.
The reporting (6)
Questions people are asking
What drove coverage for Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concern?
Coverage spiked when 6 independent newsrooms published 6 verified reports during this coverage cycle.
How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.